ToxGenSolutions B.V.
PrivateLast Round
Accelerator
Jul 2, 2024
Company Overview
ToxGenSolutions B.V. operates in Healthcare & Life Sciences and is based in Maastricht. Its latest recorded funding round was an Accelerator round in July 2024.
ToxGenSolutions B.V. is a biotechnology company that develops diagnostic tools and epigenetic biomarker fingerprints for the identification and classification of toxicants and the preclinical diagnosis of chronic pathologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ToxGenSolutions B.V. Comparables
Compare ToxGenSolutions B.V. with similar companies based on industry and business-model similarity.
No comparables are published for ToxGenSolutions B.V.. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
ToxGenSolutions B.V. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
ToxGenSolutions B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Ventures | Accelerator |
| StartUp Health | Accelerator |
| Alzheimer's Drug Discovery Foundation | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2024
Secured funding from Gates Ventures and StartUp Health.
- Jun 5, 2024
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
ToxGenSolutions B.V. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ToxGenSolutions B.V.'s valuation, stock price, and market status.
Is ToxGenSolutions B.V. a public or private company?
ToxGenSolutions B.V. is a private company.
What is the current stock price of ToxGenSolutions B.V.?
ToxGenSolutions B.V. is a private company, so its shares have no public market price. Caplight tracks ToxGenSolutions B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ToxGenSolutions B.V. worth (valuation)?
Valuation information for ToxGenSolutions B.V. is not publicly available.
Can I buy ToxGenSolutions B.V. stock?
ToxGenSolutions B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ToxGenSolutions B.V.'s last funding round?
ToxGenSolutions B.V.'s most recent funding round was Accelerator on July 2, 2024.
Who are the main investors in ToxGenSolutions B.V.?
Key investors in ToxGenSolutions B.V. include Gates Ventures, StartUp Health, Alzheimer's Drug Discovery Foundation.
Will ToxGenSolutions B.V. IPO soon?
No public IPO plans have been announced for ToxGenSolutions B.V..
How can I track ToxGenSolutions B.V. secondary market activity?
Caplight tracks bids, offers, and trades in ToxGenSolutions B.V.'s shares on secondary markets.